"This successful text is a comprehensive guide on modern cancer treatments that aims to give clinician and student alike the framework for an integrated approach to patient care, including radiotherapy, chemotherapy, and surgery. Information is presentedin tables and charts for easy assimilation, and clear algorithms for patient pathways are included to make decisions straightforward while allowing for sound clinical judgement"--
This successful text is a comprehensive guide on modern cancer treatments that aims to give clinician and student alike the framework for an integrated approach to patient care, including radiotherapy, chemotherapy, and surgery.
This successful text is a comprehensive guide on modern cancer treatments that aims to give clinician and student alike the framework for an integrated approach to patient care, including radiotherapy, chemotherapy, and surgery. Information is presented in tables and charts for easy assimilation, and clear algorithms for patient pathways are included to make decisions straightforward while allowing for sound clinical judgement.
Professor Pat Price
, MA, MD, FRCP, FROR, Visiting Professor in the Department of Surgery and Cancer, Imperial College London, is an academic clinical oncologist specializing in PET based molecular imaging, advanced radiotherapy techniques, and translational research in oncology. She founded and chairs the charity Radiotherapy UK, which acts as the secretariat to the All Party Parliamentary Group on Radiotherapy in the UK. She is also the founder and chair of the Global Coalition for Radiotherapy.
Professor Karol Sikora
, MA, MB BChir, PhD, FRCR, FRCP, FFPM, a former chief of the World Health Organization cancer programme, is a world respected oncologist and campaigner for better universal cancer treatment. He was Clinical Director for Cancer Services at Imperial Healthcare for over 20 years and founded the University of Buckingham Medical School before creating a global network of integrated cancer centres.
Preface.
List of contributors
Introduction: Cancer Care-The Future [ Online Only]
1. Central Nervous System. 2. Adult Ocular and Orbital (Ocular Adnexa) Tumours. 3. Head and Neck Cancer. 4. Thyroid. 5. Endocrine and Neuroendocrine Tumours. 6. Breast Cancer. 7. Thoracic Malignancies. 8. Esophageal Cancer. 9. Hepatocellular Carcinoma. 10. Pancreatic Cancer. 11. Biliary Tract Cancer. 12. Gastric Cancer. 13. Bladder Cancer. 14. Prostate Cancer. 15. Colorectal Cancer. 16. Anal Cancer. 17. Germ Cell Cancer of the Testis and Related Neoplasms. 18. Renal Cell Cancer. 19. Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. 20. Endometrial Cancer. 21. Cervical Cancer. 22. Carcinoma of the Vagina and Vulva. 23. Gestational Trophoblastic Neoplasia. 24. Non-Melanoma Skin Cancer. 25. Malignant Melanoma. 26. Primary Bone Tumours. 27. Soft Tissue Sarcomas. 28. Leukemias. 29. Hodgkin Lymphoma. 30. Non-Hodgkin Lymphoma. 31. Multiple Myeloma. 32. Paediatric Oncology. 33. AIDS-Related Malignancy. 34. Clinical Cancer Genetics. 35. Lifestyle Factors in Cancer Survivorship. 36. Developments in Immunotherapy. 37. Advances and Innovation in Precision Radiotherapy. 38. Policy and Cancer Care.
Index.
Professor Pat Price, MA, MD, FRCP, FRCR, Visiting Professor in the Department of Surgery and Cancer, Imperial College London, is an academic clinical oncologist specializing in PET based molecular imaging, advanced radiotherapy techniques, and translational research in oncology. She founded and chairs the charity Radiotherapy UK, which acts as the secretariat to the All Party Parliamentary Group on Radiotherapy in the UK. She also the founder and chair of the Global Coalition for Radiotherapy.
Professor Karol Sikora, MA, MB BChir, PhD, FRCR, FRCP, FFPM, a former chief of the World Health Organisation cancer programme, is a world respected oncologist and campaigner for better universal cancer treatment. He was Clinical Director for Cancer Services at Imperial Healthcare for over 20 years and founded the University of Buckingham Medical School, before creating a global network of integrated cancer centres.
Lisainfo e-raamatute kohta